726
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Greenlandic patients with colorectal cancer: symptomatology, primary investigations and differences in diagnostic intervals between Nuuk and the rest of the country

, , ORCID Icon &
Article: 1344086 | Received 15 Feb 2017, Accepted 10 Jun 2017, Published online: 14 Jul 2017

References

  • Kræftredegørelsen 2011. Department of Health. Government of Greenland; 2011. Available from: http://www.peqqik.gl/Footerpages/Publikationer/Rapporter [Danish].
  • Kræftplanen (National cancer plan). Department of Health. Government of Greenland; 2013. Available from: http://www.peqqik.gl/Footerpages/Publikationer/Rapporter [Danish].
  • Friborg J, Koch A, Wohlfarht J, et al. Cancer in Greenlandic Inuit 1973–1997: a cohort study. Int J Cancer. 2003 Dec 20;107(6):1–9.
  • Young TK, Kelly JJ, Friborg J, et al. Cancer among circumpolar populations: an emerging public health concern. Int J Circumpolar Health. 2016;75:29787.
  • Danish Colorectal Cancer Group. DCCG’S Nationale Retningslinier for Diagnostik og Behandling af Kolorektal Cancer [DCCG’S National Guidelines for Diagnostics and Treatment of Colorcale Cancer]. 2012. Available from: dccg.dk/retningslinjer/20150505/2015_usprogram.pdf [Danish].
  • Weller D, Vedsted P, Rubin G, et al. The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer. 2012 Mar 27;106(7):1262–1267.
  • Majumdar SR, Fletcher RH, Evans AT. How does colorectal cancer present? Symptoms, duration, and clues to location. Am J Gastroenterol. 1999 Oct;94(10):3039–3045.
  • Ramos M, Esteva M, Cabeza E, et al. Lack of association between diagnostic and therapeutic delay and stage of colorectal cancer. Eur J Cancer Oxf Engl 1990. 2008 Mar;44(4):510–521.
  • Tørring ML, Frydenberg M, Hansen RP, et al. Time to diagnosis and mortality in colorectal cancer: a cohort study in primary care. Br J Cancer. 2011 Mar 15;104(6):934–940.
  • Moore JS, Aulet TH. Colorectal cancer screening. Surg Clin North Am. 2017 Jun;97(3):487–502.
  • Esteva M, Leiva A, Ramos M, et al. Factors related with symptom duration until diagnosis and treatment of symptomatic colorectal cancer. BMC Cancer. 2013 Feb;23(13):87.
  • Arbman G, Nilsson E, Störgren-Fordell V, et al. A short diagnostic delay is more important for rectal cancer than for colonic cancer. Eur J Surg Acta Chir. 1996 Nov;162(11):899–904.
  • Sladden MJ, Thomson AN. How do general practitioners manage rectal bleeding? Aust Fam Physician. 1998 Feb;27(1–2):78–82.
  • Chan BTB, Austin PC. Patient, physician, and community factors affecting referrals to specialists in Ontario, Canada: a population-based, multi-level modelling approach. Med Care. 2003 Apr;41(4):500–511.
  • van Walraven C, Oake N, Jennings A, et al. The association between continuity of care and outcomes: a systematic and critical review. J Eval Clin Pract. 2010 Oct;16(5):947–956.
  • Vega P, Valentín F, Cubiella J. Colorectal cancer diagnosis: pitfalls and opportunities. World J Gastrointest Oncol. 2015 Dec 15;7(12):422–433.
  • Mitchell E, Macdonald S, Campbell NC, et al. Influences on pre-hospital delay in the diagnosis of colorectal cancer: a systematic review. Br J Cancer. 2008 Jan 15;98(1):60–70.
  • Korsgaard M, Pedersen L, Sørensen HT, et al. Reported symptoms, diagnostic delay and stage of colorectal cancer: a population-based study in Denmark. Colorectal Dis Off J Assoc Coloproctology G B Irel. 2006 Oct;8(8):688–695.
  • Langenbach MR, Schmidt J, Neumann J, et al. Delay in treatment of colorectal cancer: multifactorial problem. World J Surg. 2003 Mar;27(3):304–308.
  • Young CJ, Sweeney JL, Hunter A. Implications of delayed diagnosis in colorectal cancer. Aust N Z J Surg. 2000 Sep;70(9):635–638.
  • Traul DG, Davis CB, Pollock JC, et al. Flexible fiberoptic sigmoidoscopy–the Monroe Clinic experience. A prospective study of 5000 examinations. Dis Colon Rectum. 1983 Mar;26(3):161–166.
  • Jellema P, van der Windt DAWM, Bruinvels DJ, et al. Value of symptoms and additional diagnostic tests for colorectal cancer in primary care: systematic review and meta-analysis. Bmj. 2010 Mar;31(340):c1269.
  • John SKP, George S, Primrose JN, et al. Symptoms and signs in patients with colorectal cancer. Colorectal Dis Off J Assoc Coloproctology G B Irel. 2011 Jan;13(1):17–25.
  • Bjerregaard P, Dahl-Petersen IK. Befolkningsundersøgelse I Grønland 2005–2007, Levevilkår, livstil og Helbred. Copenhagen: Syddansk Universitet: Statens Institut for Folkesundhed; 2008. p. 1-174 [Danish].
  • Hewitson P, Glasziou P, Watson E, et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 2008 Jun;103(6):1541–1549.
  • Sundhedsstyrrelsen. Anbefalinger vedrørende screening for tyk- og endetarmskræft. 2012. Available from: https://www.sst.dk/da/udgivelser/2012/~/media/1327A2433DDD454C86D031D50FE6D9D6.ashx [Danish].
  • van Rossum LG, Van Rijn AF, Laheij RJ, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology. 2008 Jul;135(1):82–90.
  • Dunkle A, Blackwell E, Jaros R, et al. Greenland colorectal cancer screening: costing analysis. Government of Greenland;2017.
  • Cole AM, Jackson JE, Doescher M. Urban-rural disparities in colorectal cancer screening: cross-sectional analysis of 1998-2005 data from the Centers for Disease Control’s Behavioral Risk Factor Surveillance Study. Cancer Med. 2012 Dec;1(3):350–356.
  • Klabunde CN, Cronin KA, Breen N, et al. Trends in colorectal cancer test use among vulnerable populations in the USA. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsor Am Soc Prev Oncol. 2011 Aug;20(8):1611–1621.
  • Essink-Bot M-L, Dekker E. Equal access to colorectal cancer screening. Lancet Lond Engl. 2016 Feb 20;387(10020):724–726.